Insider Transactions in Q1 2024 at Tyra Biosciences, Inc. (TYRA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Alan Fuhrman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
932
+28.01%
|
$11,184
$12.48 P/Share
|
|
Mar 15
2024
|
Hiroomi Tada Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,968
+2.23%
|
$11,808
$6.58 P/Share
|
|
Mar 15
2024
|
Todd Harris President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,880
+0.12%
|
$11,280
$6.58 P/Share
|
|
Mar 11
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
200
-0.05%
|
$4,000
$20.0 P/Share
|
|
Mar 07
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
68
-0.02%
|
$1,360
$20.0 P/Share
|
|
Mar 06
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,733
-0.4%
|
$34,660
$20.09 P/Share
|
|
Mar 05
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,189
-0.27%
|
$23,780
$20.02 P/Share
|
|
Mar 04
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,063
-1.15%
|
$101,260
$20.08 P/Share
|
|
Mar 01
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,900
-0.65%
|
$58,000
$20.04 P/Share
|
|
Feb 29
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,050
-0.46%
|
$41,000
$20.0 P/Share
|
|
Feb 28
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,849
-1.3%
|
$116,980
$20.13 P/Share
|
|
Feb 27
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
745
-0.17%
|
$14,900
$20.0 P/Share
|
|
Feb 12
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,501
-0.33%
|
$30,020
$20.0 P/Share
|
|
Feb 07
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,587
-2.07%
|
$172,566
$18.09 P/Share
|
|
Feb 06
2024
|
Ra Capital Management, L.P. |
BUY
Grant, award, or other acquisition
|
Indirect |
3,180,155
+27.28%
|
$41,342,015
$13.01 P/Share
|
|
Feb 06
2024
|
Boxer Capital, LLC |
BUY
Grant, award, or other acquisition
|
Indirect |
63,412
+42.46%
|
$824,356
$13.01 P/Share
|
|
Feb 06
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
15,413
-3.22%
|
$277,434
$18.09 P/Share
|
|
Feb 05
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
13,817
-0.91%
|
$221,072
$16.97 P/Share
|
|
Feb 02
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
86,183
-2.7%
|
$1,378,928
$16.75 P/Share
|
|
Feb 02
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
75,393
-6.84%
|
$1,206,288
$16.68 P/Share
|
|
Feb 02
2024
|
Daniel Bensen Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,393
+4.39%
|
$0
$0.61 P/Share
|